🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/02/2020 | 98,04 | 103,22 | 97,28 | 102,96 | +2,15% | 6,06% | 997.700 |
| 27/02/2020 | 104,79 | 105,27 | 100,72 | 100,79 | -4,74% | 4,34% | 1.035.300 |
| 26/02/2020 | 104,44 | 109,31 | 104,00 | 105,81 | -6,25% | 5,08% | 1.532.800 |
| 25/02/2020 | 116,42 | 116,64 | 110,06 | 112,86 | -2,16% | 5,65% | 763.300 |
| 24/02/2020 | 112,01 | 116,98 | 111,07 | 115,35 | +7,84% | 5,28% | 1.038.600 |
| 21/02/2020 | 107,29 | 108,44 | 106,71 | 106,96 | -0,43% | 1,61% | 528.300 |
| 20/02/2020 | 106,94 | 108,12 | 105,74 | 107,42 | +0,47% | 2,23% | 407.500 |
| 19/02/2020 | 106,41 | 107,83 | 106,24 | 106,92 | +0,89% | 1,49% | 391.400 |
| 18/02/2020 | 104,03 | 106,11 | 103,13 | 105,98 | +1,72% | 2,86% | 246.700 |
| 14/02/2020 | 104,26 | 105,30 | 103,23 | 104,19 | +0,19% | 1,99% | 236.800 |
| 13/02/2020 | 105,00 | 105,46 | 103,65 | 103,99 | -0,45% | 1,72% | 336.600 |
| 12/02/2020 | 101,89 | 105,93 | 101,70 | 104,46 | +3,27% | 4,15% | 899.300 |
| 11/02/2020 | 100,21 | 101,65 | 99,06 | 101,15 | +1,13% | 2,58% | 345.100 |
| 10/02/2020 | 100,84 | 100,84 | 98,51 | 100,02 | -0,50% | 2,31% | 311.900 |
| 07/02/2020 | 101,44 | 101,57 | 99,56 | 100,52 | -0,91% | 1,98% | 426.000 |
| 06/02/2020 | 102,08 | 102,51 | 100,54 | 101,44 | -0,03% | 1,93% | 440.800 |
| 05/02/2020 | 97,21 | 103,41 | 97,21 | 101,47 | +4,99% | 6,38% | 566.200 |
| 04/02/2020 | 95,25 | 96,85 | 95,25 | 96,65 | +1,14% | 1,68% | 351.900 |
| 03/02/2020 | 94,17 | 96,59 | 90,02 | 95,56 | -2,16% | 6,98% | 1.097.800 |
| 31/01/2020 | 99,04 | 99,48 | 97,02 | 97,67 | +1,37% | 2,48% | 386.100 |
| 30/01/2020 | 95,47 | 100,09 | 94,83 | 96,35 | -0,07% | 5,51% | 483.900 |
| 29/01/2020 | 93,29 | 97,43 | 92,61 | 96,42 | +3,45% | 5,17% | 754.700 |
| 28/01/2020 | 90,56 | 93,80 | 89,30 | 93,20 | +3,50% | 4,97% | 560.500 |
| 27/01/2020 | 88,42 | 90,91 | 88,19 | 90,05 | +0,81% | 3,08% | 325.300 |
| 24/01/2020 | 91,08 | 91,35 | 88,50 | 89,33 | -1,69% | 3,13% | 351.700 |
| 23/01/2020 | 92,49 | 92,90 | 90,24 | 90,87 | -1,70% | 2,88% | 303.000 |
| 22/01/2020 | 91,95 | 92,60 | 91,00 | 92,44 | +0,61% | 1,74% | 366.800 |
| 21/01/2020 | 92,86 | 93,40 | 91,74 | 91,88 | -1,34% | 1,79% | 305.900 |
| 17/01/2020 | 94,48 | 94,75 | 92,50 | 93,13 | -1,06% | 2,38% | 482.300 |
| 16/01/2020 | 93,21 | 95,24 | 92,56 | 94,13 | +1,83% | 2,88% | 487.300 |